Sanofi will buy Dynavax for €1.867 billion

The headquarters of the French pharmaceutical company Sanofi, in Paris Benoit Tessier / Reuters

1 min

French pharmaceutical company Sanofi has reached an agreement to acquire Dynavax Technologies Corporation (Dynavax), a US laboratory that markets a vaccine against hepatitis B for adults (HEPLISAV-B) and a candidate against shingles, for the equivalent of 1.867 billion euros.

Sanofi will buy Dynavax for €1.867 billion

The 20 best Christmas movies (new and classic) you can watch on streaming platforms

The mystery of the invented animal that is eaten at Christmas in only one place in the world

Economic injection of 269 million euros for the bioeconomy

Catalan separatists react against the king's speech

Civil Protection asks people to bring forward their return home at Christmas and delay it for Boxing Day due to bad weather.

A musical Christmas in Catalan: the Palau's videopodcast in 'Rehearsal Room' for these holidays

The 20 best Christmas movies (new and classic) you can watch on streaming platforms

San Esteban with a severe easterly storm and snow in the eastern Pyrenees

Sailing through the wildest waters with a Catalan sailing dinghy

Carme Noguera, the oldest woman in Catalonia: "I ask the King and Queen for health and to make me a little younger!"